Agilent Sheds Hycor Biomedical Business

A private equity firm has purchased Hycor, which was not a strategic fit for Agilent's operations.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories